Biotech: Pressemitteilungen - Kategorie - Seite 208

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Calyx Operating Subsidiary Participates in Canada's First Bio-Fuel Powered Revenue Flight

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/17/12 -- Calyx Bio-Ventures Inc. ("Calyx" or the "Company") (TSX VENTURE: CYX) is pleased to announce that the Company's o ...

WorldCare Clinical Appoints New Executive Director of Quality & Regulatory Affairs

BOSTON, MA: Seasoned Veteran Brings Extensive Quality, Computer Systems and Regulatory Background to Imaging CRO ...

TiGenix : Rheumatoid Arthritis Phase IIa Study Successfully Passes Last Safety Hurdle

LEUVEN, BELGIUM and MADRID, SPAIN: LEUVEN, BELGIUM and MADRID, SPAIN -- (Marketwire) -- 04/17/12 -- TiGenix (EURONEXT BRUSSELS: TIG) announced today that upon review of the safety data of the first three patients of the third cohort ...

Warnex Obtains Extension for the Repayment of its Debentures

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 04/16/12 -- Warnex Inc. (TSX: WNX) ("Warnex") announces that Persistence Capital Partners LP ("PCP"), the holder of its outstanding debentures (t ...

Miraculins Announces Board Members

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 04/16/12 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk asse ...

Mediatum Co-Founder to Speak at Boston Biotech Conference

CAMBRIDGE, MA: Christoph Boehringer Is Co-Founder of Global Life Sciences Executive Search Firm ...

BARDA Exercises $9.1 Million in Contract Options With Aeolus

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 04/16/12 -- , Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds in onc ...

FDA Schedules Meeting With Cellceutix on New Psoriasis Drug

BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 04/16/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a biopharmaceutical company developing small molecule drugs to treat severe medical conditi ...

Threshold Pharmaceuticals Announces Presentation and Webcast at BioCentury Future Leaders Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/13/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Chief Executive Officer of Threshold, is scheduled to pre ...

Theratechnologies Announces Financial Results for First Quarter of 2012

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 04/13/12 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH)(NASDAQ: THER) today announced its financial results for the first quarter ended February 29, 2012 ...

Break-Through Invention for Treating Cancer -- Australian Biotech Company Completes Round 1 Funding

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 04/13/12 -- ImmunAid Pty. Ltd., a private Australian-based biotechnology company, is delighted to inform the market that it has successfully completed its fir ...

Genetic Technologies' Subsidiary Update

MELBOURNE, AUSTRALIA: ImmunAid Secures Cornerstone Funding ...

Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2012

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 04/12/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and de ...

REMINDER/Theratechnologies to Announce Financial Results for First Quarter of 2012

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 04/12/12 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) (Theratechnologies) announced today that it will issue its financial results for the first quarter end ...

Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering

PHILADELPHIA, PA and REHOVOT, ISRAEL: PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 04/12/12 -- Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnosti ...

North America Remains Strongest Link in Global Pharma-Biotech Industry Chain, a "Navigating the Currents of Change" Webcast on Industrialinfo.com

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 04/12/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There is no arguing that the entire has undergone a massive reorganizatio ...

Lonza and Agennix Sign Development and Manufacturing Deal for Production of Talactoferrin

BASEL, SWITZERLAND and PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: Contract Covers the Commercial Production of Talactoferrin, an Oral Dendritic Cell Mediated Immunotherapy (DCMI) Under Investigation for the Treatment of Non-Small Cell Lung Cancer (NSCLC); Lonza Will ...

Lorus Therapeutics Announces Allowance of United States Patent for Anticancer Drug LOR-253

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 04/11/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...

Mymetics Appoints Grant Pickering CEO and Christopher Henney Chairman

EPALINGES, SWITZERLAND: - Grant E. Pickering named President and CEO - Dr. Christopher Henney appointed Chairman of the Board of Directors - Election of new members to the Board of Directors ...


Seite 208 von 255:  « ..  207 208 209  210  211  212  213  214  215  216  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z